Johnson & Johnson to buy Actelion for $30bln

Sharing is Caring

U.S. healthcare giant Johnson & Johnson will buy Swiss biotech company Actelion in a $30 billion all-cash deal that includes spinning off Actelion’s research and development pipeline. Ivor Bennett reports

Johnson & Johnson to buy Actelion for $30bln

Tags : Takeover, Takeoveractelion, Pharmaceutical, merger, Ma, Johnson johnson, drugs, Actelion

Related Videos :

You may also like...

Leave a Reply